MET and neural tube defect: To further verify whether the HGF/c-MET pathway plays a critical role in NTD lesion-specific migration of BMSCs, an anti-HGF antibody or c-MET inhibitor was used to inhibit the activity of HGF in BMSCs or c-MET in the defective neural tube before transplantation, respectively.